Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare but highly morbid
complication after adenoviral vector-based SARS-CoV-2 vaccination. The pre-VITT …

Background Rapid diagnosis and treatment has improved outcome of patients with vaccine-
induced immune thrombocytopenia and thrombosis (VITT). However, after the acute …

Antibodies against the chemokine platelet factor 4 (PF4) occur often, but only those that
activate platelets induce severe prothrombotic disorders with associated thrombocytopenia …

Purpose We reported the first described post Ad26. COV2. S (Janssen, Johnson & Johnson)
vaccine-induced immune thrombocytopenia (VITT) case outside US. Case description CA …

This scoping review aims to 1) identify characteristics of participants who developed
embolism and/or thrombotic event (s) after COVID-19 vaccination and 2) review the …

Cerebral venous sinus thrombosis (CVST) following novel coronavirus-2019 (nCoV-19)
vaccination is a rare adverse effect. We report the first case of CVST associated with …

Objective Describe a case series of vaccine-induced immune thrombotic thrombocytopenia
(VITT) after COVID-19 vaccination in Brazil that included ChAdOx1 nCoV-19, Ad26. COV2. S …

This is a revision of the online November 2021 Brighton thrombosis with thrombocytopenia
syndrome (TTS) case definition and a new Brighton Collaboration case definition for vaccine …

Background Vaccine-induced thrombosis and thrombocytopenia (VITT) is a rare
complication following ChAdOx1 nCoV-19 vaccination. Cerebral venous sinus thrombosis …

Background The emergence of new variants of SARS-CoV-2 has led to the administration of
different booster vaccines to mitigate COVID-19. Vaccines with adenoviral vectors have …